Reported covered position: DTA- Lobbyist
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Access to Prescription Digital Therapeutics Act of 2022
Client: DIGITAL THERAPEUTICS ALLIANCE, INC · Firm: DIGITAL THERAPEUTICS ALLIANCE, INC
H.R.7051 - Access to Prescription Digital Therapeutics Act of 2022 S.3791 - Access to Prescription Digital Therapeutics Act of 2022
Access to Prescription Digital Therapeutics Act of 2022
Client: DIGITAL THERAPEUTICS ALLIANCE, INC · Firm: DIGITAL THERAPEUTICS ALLIANCE, INC
H.R.7051 - Access to Prescription Digital Therapeutics Act of 2022 S.3791 - Access to Prescription Digital Therapeutics Act of 2022
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DIGITAL THERAPEUTICS ALLIANCE, INC via DIGITAL THERAPEUTICS ALLIANCE, INC
2022 · third_quarter · 3A
H.R.7051 - Access to Prescription Digital Therapeutics Act of 2022 S.3791 - Access to Prescription Digital Therapeutics Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGITAL THERAPEUTICS ALLIANCE, INC via DIGITAL THERAPEUTICS ALLIANCE, INC
2020 · first_quarter · Q1
Source: Senate LDA
The use of digital therapeutics to treat, manage, and prevent diseases.
The use of digital therapeutics to treat, manage, and prevent diseases.
The use of digital therapeutics to treat, manage, and prevent diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE